Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Efficacy of RTS,S/AS01 Malaria Vaccine in African Infants and Children
NCT00866619Phase 3Completed
- Sponsor
- GSK
- Start
- Mar 2009
- Primary completion
- Mar 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 7
01
Overview
A Phase 3 trial of RTS,S in Plasmodium falciparum malaria, sponsored by GSK. Started Mar 2009; status: completed.
02
Drugs
RTS,S
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT00866619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00866619.